Intech Investment Management LLC bought a new position in National Health Investors, Inc. (NYSE:NHI - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 8,563 shares of the real estate investment trust's stock, valued at approximately $720,000.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Connor Clark & Lunn Investment Management Ltd. bought a new position in National Health Investors in the 3rd quarter worth approximately $282,000. Aviance Capital Partners LLC grew its stake in shares of National Health Investors by 6.2% in the third quarter. Aviance Capital Partners LLC now owns 3,788 shares of the real estate investment trust's stock worth $318,000 after acquiring an additional 221 shares during the last quarter. Quest Partners LLC bought a new stake in National Health Investors in the 3rd quarter valued at $230,000. Thrivent Financial for Lutherans bought a new position in shares of National Health Investors during the 3rd quarter worth about $2,426,000. Finally, Metis Global Partners LLC increased its holdings in shares of National Health Investors by 31.2% during the 3rd quarter. Metis Global Partners LLC now owns 4,474 shares of the real estate investment trust's stock worth $376,000 after purchasing an additional 1,065 shares during the period. Institutional investors and hedge funds own 62.51% of the company's stock.
Analysts Set New Price Targets
A number of equities research analysts recently weighed in on NHI shares. Truist Financial lifted their target price on National Health Investors from $65.00 to $78.00 and gave the stock a "hold" rating in a research report on Friday, August 30th. Wells Fargo & Company lowered National Health Investors from an "overweight" rating to an "equal weight" rating and upped their target price for the company from $81.00 to $86.00 in a research note on Tuesday, October 1st. StockNews.com downgraded shares of National Health Investors from a "buy" rating to a "hold" rating in a research note on Tuesday, October 15th. Finally, Bank of America initiated coverage on shares of National Health Investors in a research note on Tuesday, September 24th. They issued a "buy" rating and a $92.00 price objective for the company. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $76.33.
Check Out Our Latest Report on National Health Investors
National Health Investors Price Performance
NYSE:NHI traded down $0.26 on Friday, reaching $76.65. The stock had a trading volume of 207,862 shares, compared to its average volume of 198,208. The company has a market capitalization of $3.48 billion, a P/E ratio of 26.34, a price-to-earnings-growth ratio of 5.13 and a beta of 1.05. The stock has a fifty day moving average price of $78.75 and a 200-day moving average price of $74.77. The company has a quick ratio of 10.29, a current ratio of 10.29 and a debt-to-equity ratio of 0.92. National Health Investors, Inc. has a 1-year low of $51.59 and a 1-year high of $86.13.
National Health Investors (NYSE:NHI - Get Free Report) last released its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 EPS for the quarter, missing analysts' consensus estimates of $1.07 by ($0.42). The business had revenue of $63.32 million for the quarter, compared to the consensus estimate of $67.93 million. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The firm's revenue was up 1.7% on a year-over-year basis. During the same quarter last year, the company earned $1.08 earnings per share. Research analysts forecast that National Health Investors, Inc. will post 4.42 EPS for the current year.
National Health Investors Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 29th. Stockholders of record on Tuesday, December 31st will be given a dividend of $0.90 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.70%. National Health Investors's payout ratio is 123.71%.
National Health Investors Profile
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Read More
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
